Prevalence and Prognosis of Cerebrovascular Accidents and its Subtypes Among Patients with Systemic Lupus Erythematosus in Isfahan, Iran: A Hospital Clinic-based Study
- PMID: 24555002
- PMCID: PMC3915465
Prevalence and Prognosis of Cerebrovascular Accidents and its Subtypes Among Patients with Systemic Lupus Erythematosus in Isfahan, Iran: A Hospital Clinic-based Study
Abstract
Background: The aim of the present study was to determine the prevalence and prognosis of cerebrovascular accident (CVA) and its subtypes among Iranian patients with systemic lupus erythematosus (SLE).
Methods: In a cross-sectional study, medical records of 575 SLE patients were reviewed. The patients developing CVA in their course of disease were extracted. In these patients, data about demographic features, lupus anti bodies, duration of the disease until CVA, CVA manifestation(s) and follow-up duration were gathered. In the next step, patients with any kinds of CVA were summoned to Neurology clinic to identify the grade of disability in each patient with CVA.
Results: We identified 38 patients with CVA of which 6 (15.8%) were men and 32 (84.2%) were women. The most common subtype of CVA was small vessels thrombosis (21.05%) among the study patients and hemi paresis was the most prevalent initial presentation (39.47%). In 11 (28.9%) patients, SLE was initiated with CVA and in 3 (7.9%) patients CVA had happened in the 1(st) year of SLE. Anti-phospholipid antibodies (APLA) were positive in 29 (76.3%) patients. Mean modified Rankin Scale in patient with positive and negative serology for APLA was 0.93 ± 1.11 and 0.22 ± 0.66 respectively (P = 0.006).
Conclusions: Our study shows that 6.6% of Iranian SLE patients have CVA during their course of the disease. Small vessels thrombosis is the most common CVA subtype and hemi paresis is the most prevalent initial presentation. Moreover, we showed that the prognosis of CVA in Iranian SLE patients is not unfavorable.
Keywords: Cerebrovascular accident; stroke; systemic lupus erythamatosus.
Conflict of interest statement
Similar articles
-
Annual incidence and standardized incidence ratio of cerebrovascular accidents in patients with systemic lupus erythematosus.Scand J Rheumatol. 2009;38(5):362-8. doi: 10.1080/03009740902776927. Scand J Rheumatol. 2009. PMID: 19296403
-
Outcomes of hospitalizations for myocardial infarctions and cerebrovascular accidents in patients with systemic lupus erythematosus.Arthritis Rheum. 2004 Oct;50(10):3170-6. doi: 10.1002/art.20556. Arthritis Rheum. 2004. PMID: 15476215
-
Systemic Lupus Erythematosus: Symptoms and Signs at Initial Presentations.Antiinflamm Antiallergy Agents Med Chem. 2019;18(2):142-150. doi: 10.2174/1871523018666181128161828. Antiinflamm Antiallergy Agents Med Chem. 2019. PMID: 30488801
-
'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus.Rheumatology (Oxford). 2005 Dec;44(12):1492-502. doi: 10.1093/rheumatology/kei142. Epub 2005 Oct 18. Rheumatology (Oxford). 2005. PMID: 16234277 Review.
-
Stroke Is Not an Accident: An Integrative Review on the Use of the Term Cerebrovascular Accident.Neuroepidemiology. 2024 Oct 28:1-9. doi: 10.1159/000542301. Online ahead of print. Neuroepidemiology. 2024. PMID: 39467531 Review.
Cited by
-
Platelet distribution width as a novel indicator of disease activity in systemic lupus erythematosus.J Res Med Sci. 2018 May 30;23:48. doi: 10.4103/jrms.JRMS_1038_16. eCollection 2018. J Res Med Sci. 2018. PMID: 29937910 Free PMC article.
-
Neurological Manifestations of Systemic Lupus Erythematosus: A Comprehensive Review.Cureus. 2025 Feb 24;17(2):e79569. doi: 10.7759/cureus.79569. eCollection 2025 Feb. Cureus. 2025. PMID: 40151747 Free PMC article. Review.
-
The effect of Vitamin D supplementation in disease activity of systemic lupus erythematosus patients with Vitamin D deficiency: A randomized clinical trial.J Res Med Sci. 2017 Jan 27;22:4. doi: 10.4103/1735-1995.199089. eCollection 2017. J Res Med Sci. 2017. PMID: 28400826 Free PMC article.
-
Stroke in systemic lupus erythematosus: a meta-analysis of population-based cohort studies.RMD Open. 2015 Dec 16;1(1):e000168. doi: 10.1136/rmdopen-2015-000168. eCollection 2015. RMD Open. 2015. PMID: 26719816 Free PMC article. Review.
-
Cerebral venous thrombosis presenting with subdural haematoma as first presentation for systemic lupus erythematosus with negative antiphospholipid antibodies.BMJ Case Rep. 2014 Jul 30;2014:bcr2014205355. doi: 10.1136/bcr-2014-205355. BMJ Case Rep. 2014. PMID: 25080548 Free PMC article.
References
-
- Brey RL. Neuropsychiatric lupus: Clinical and imaging aspects. Bull NYU Hosp Jt Dis. 2007;65:194–9. - PubMed
-
- Schur PH, Gladman DD. Overview of the clinical manifestations of systemic lupus erythematosus in adults. In: Basow DS, editor. Up To Date. Waltham, MA: Up to Date; 2009.
-
- Futrell N, Millikan C. Frequency, etiology, and prevention of stroke in patients with systemic lupus erythematosus. Stroke. 1989;20:583–91. - PubMed
-
- Krishnan E. Stroke subtypes among young patients with systemic lupus erythematosus. Am J Med. 2005;118:1415. - PubMed
LinkOut - more resources
Full Text Sources